Charter Renewal of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 80574-80575 [2024-22794]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 80574 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices required. Please visit the ACHDNC website for information on registration: https://www.hrsa.gov/advisorycommittees/heritable-disorders/ index.html. Register no later than 12:00 p.m. ET on November 13, 2024. Instructions on how to access the meeting via webcast will be provided upon registration. FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room, Rockville, Maryland 20857; 301–443–8335; or ACHDNC@hrsa.gov. SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations to the Secretary of Health and Human Services (Secretary) on the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. ACHDNC reviews and reports regularly on newborn and childhood screening practices, recommends improvements in the national newborn and childhood screening programs, and fulfills requirements stated in the authorizing legislation. In addition, ACHDNC’s recommendations regarding inclusion of additional conditions for screening on the Recommended Uniform Screening Panel, following adoption by the Secretary, are evidence-informed preventive health services provided for in the comprehensive guidelines supported by HRSA pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 300gg–13). Under this provision, non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance are required to provide insurance coverage without cost-sharing (a co-payment, coinsurance, or deductible) for preventive services for plan years (i.e., policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition for screening. During the November 14, 2024, meeting, ACHDNC will hear from experts in the fields of public health, medicine, heritable disorders, rare disorders, and newborn screening. Possible agenda items may include the following topics: (1) An update on the development of a newborn screening family outcomes tool, (2) A panel presentation on funding opportunities for research that includes the lived experience, (3) A presentation on the Newborn Screening Information Center, and VerDate Sep<11>2014 17:59 Oct 02, 2024 Jkt 265001 (4) An update on Recommended Uniform Screening Panel condition nomination submissions. Agenda items are subject to change as priorities dictate. Information about ACHDNC, including a roster of members and past meeting summaries, is available on the ACHDNC website listed above. Members of the public will have the opportunity to provide comments on any of the above agenda items. Public participants may request to provide general oral comments and may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to provide a written statement or make oral comments to ACHDNC must be submitted via the registration website by 12:00 p.m. ET on Thursday, October 31, 2024. Written comments will be shared with the Committee prior to the meeting so they have an opportunity to consider them in advance of the meeting. Individuals who need special assistance or another reasonable accommodation should notify Leticia Manning at the address and phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–22733 Filed 10–2–24; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Charter Renewal of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the charter for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) has been renewed. FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, SUMMARY: PO 00000 Frm 00123 Fmt 4703 Sfmt 4703 Rockville, MD 20852. Phone: 202–746– 1512; Email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), established by Executive Order 13676, is continued by section 505 of Public Law 116–22, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92– 463, as amended (5 U.S.C. app.), which sets forth standards for the formation and use of Federal advisory committees. FACA stipulates that the charter for a Federal advisory committee must be renewed every two years. The PACCARB shall advise and provide information and recommendations to the Secretary of Health and Human Services (Secretary) regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes. Such advice, information, and recommendations may be related to improving: the effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities; surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance. On August 29, 2024, the Secretary of Health and Human Services approved the renewal of the PACCARB’s charter. The new charter was executed and filed with the appropriate Congressional committees and the Library of Congress on August 29, 2024. The renewal of the E:\FR\FM\03OCN1.SGM 03OCN1 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices charter gives the PACCARB authorization to operate until August 29, 2026. A copy of the charter is available on the PACCARB’s website at: www.hhs.gov/paccarb. Dated: September 26, 2024. B. Kaye Hayes, Director, Office of Infectious Disease and HIV/ AIDS Policy, Office of the Assistant Secretary for Health. [FR Doc. 2024–22794 Filed 10–2–24; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council on Alzheimer’s Research, Care, and Services; Meeting Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. AGENCY: This notice announces the public meeting of the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. During the meeting, the Advisory Council will hear updates from federal agencies on activities during the last quarter and from panels organized by the clinical care and risk reduction subcommittees. Presenters will discuss dementia care from different perspectives, including those of providers, people with lived experience, and CMMI GUIDE Model participants, as well as how to bridge gaps in service delivery. DATES: The meeting will be October 21, 2024, from 9:30 a.m. to 4:30 p.m. ADDRESSES: The meeting will be a hybrid of in-person and virtual. The meeting will be held in Room 800 of the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. It will also stream live at www.hhs.gov/live. Comments: Time is allocated on the agenda to hear public comments from 4:00 p.m. to 4:25 p.m. on Monday, October 21. The time for oral comments will be limited to two (2) minutes per individual. To provide a public comment, please register by emailing your name to napa@hhs.gov by Wednesday, October 16. Registered commenters will receive both a dial-in number and a link to join the meeting virtually; individuals will have the choice to either join virtually via the link, or to call in only by using the dialin number. Note: There may be a 30–45 ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:59 Oct 02, 2024 Jkt 265001 second delay in the livestream video presentation of the conference. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. Public commenters will not be admitted to the virtual meeting before 3:30 p.m. but are encouraged to watch the meeting at www.hhs.gov/live. Should you have questions during the session, please email napa@hhs.gov and someone will respond to your message as quickly as possible. To ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@hhs.gov by Wednesday, October 23, 2024. These comments will be shared on the website and reflected in the meeting minutes. In lieu of oral comments, formal written comments may be submitted for the record by Wednesday, October 23, 2024, to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@ hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202–260–6075, helen.lamont@hhs.gov. Note: The meeting will be available to the public live at www.hhs.gov/live. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: Alzheimer’s disease-related dementias, clinical care, risk reduction. Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer’s Project Act website when available after the meeting. This meeting is open to the public. Please allow 30 minutes to go through security and walk to the meeting room. Participants joining in person should note that seating may be limited. Those wishing to attend the meeting in person must send an email to napa@hhs.gov and put ‘‘October 21 Meeting Attendance’’ in the subject line by Wednesday, October 16 so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information PO 00000 Frm 00124 Fmt 4703 Sfmt 4703 80575 at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. Dated: September 17, 2024. Tisamarie B. Sherry, Deputy Assistant Secretary for Behavioral Health, Disability, and Aging Policy, performing the delegable duties of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2024–22763 Filed 10–2–24; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Charter Renewal of the Secretary’s Advisory Committee on Human Research Protection Office for Human Research Protections, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The Department of Health and Human Services is hereby giving notice that the charter for the Secretary’s Advisory Committee on Human Research Protection (SACHRP) has been renewed. FOR FURTHER INFORMATION CONTACT: Ms. Julia Gorey, Designated Federal Officer for the SACHRP, Office for Human Research Protections, 1101 Wootton Parkway, Rockville, MD 20852. Phone: (240) 453–8141; Email: SACHRP@ hhs.gov. SUPPLEMENTARY INFORMATION: SACHRP is a discretionary Federal advisory committee. SACHRP is authorized under 42 U.S.C. 217a, Section 222 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C. app), which sets forth standards for the formation and use of advisory committees. SACHRP functions to provide advice to the Secretary, through the Assistant Secretary for Health, on matters SUMMARY: E:\FR\FM\03OCN1.SGM 03OCN1

Agencies

[Federal Register Volume 89, Number 192 (Thursday, October 3, 2024)]
[Notices]
[Pages 80574-80575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22794]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Charter Renewal of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the charter for the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria (PACCARB) has been renewed.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are 
governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth 
standards for the formation and use of Federal advisory committees. 
FACA stipulates that the charter for a Federal advisory committee must 
be renewed every two years.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary of Health and Human Services 
(Secretary) regarding programs and policies intended to reduce or 
combat antibiotic-resistant bacteria that may present a public health 
threat and improve capabilities to prevent, diagnose, mitigate, or 
treat such resistance. The PACCARB shall function solely for advisory 
purposes.
    Such advice, information, and recommendations may be related to 
improving: the effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce 
the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    On August 29, 2024, the Secretary of Health and Human Services 
approved the renewal of the PACCARB's charter. The new charter was 
executed and filed with the appropriate Congressional committees and 
the Library of Congress on August 29, 2024. The renewal of the

[[Page 80575]]

charter gives the PACCARB authorization to operate until August 29, 
2026.
    A copy of the charter is available on the PACCARB's website at: 
www.hhs.gov/paccarb.

    Dated: September 26, 2024.
B. Kaye Hayes,
Director, Office of Infectious Disease and HIV/AIDS Policy, Office of 
the Assistant Secretary for Health.
[FR Doc. 2024-22794 Filed 10-2-24; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.